OVERVIEW
AB Science
A French pharmaceutical company specializing in the research, discovery, development and commercialization of innovative drugs.
Founded in 2001
AB Science is a late-clinical-stage French company founded in 2001 by a team of scientists with the goal of developing innovative drugs for diseases with high unmet medical needs.
Paris · Euronext
The Company is based in Paris and has been listed on Euronext since 2010 (Compartment B, Paris, France).
Nearly 40 employees
AB Science has nearly 40 employees, primarily dedicated to R&D activities.
Two main compounds
AB Science is currently developing two main compounds: masitinib, a highly selective tyrosine kinase inhibitor, and AB8939, a new-generation microtubule destabilizer.
GOVERNANCE
Executive Committee
Stéphane LEDERMANN
Chairman and Chief Executive Officer
Franco-Swiss entrepreneur and shareholder of AB Science since 2012, graduated from Paris Dauphine University.
Laurent GUY
Chief Operating Officer
Previously held positions in the banking industry (Société Générale and Paribas) and in strategy consulting (Accenture).
Christian FASSOTTE
Chief Medical Officer
Medical Doctor with more than 30 years of experience, including executive positions at Sanofi and Roche in Medical Affairs, Regulatory Affairs and R&D.
Alexis Bernard
Head of Veterinary Sales
Former strategy consultant at Stanwell Consulting.
EXPERTISE
Scientific Committee
The Scientific Committee was established in 2002 to define the Company’s main scientific programs.
- Olivier Hermine (MD)
Professor of Hematology at Paris V-René Descartes University. Head of the Adult Hematology Department at Necker Hospital (Paris), member of the French Academy of Sciences, elected to the Collège de France (Chair of Experimental Medicine), and author of more than 900 publications in peer-reviewed international scientific journals.
- Christian Auclair (MD)
Head of Biology Practice at École Normale Supérieure de Cachan. Associate Director of the Life Sciences Department at the CNRS from 1996 to 2000.
Scientific Director of AB SCIENCE
- Patrice Dubreuil (MD)
Doctor in Immunology and Level 1 Research Director at Inserm. Recognized expert in signal transduction pathways and kinase biology.
OUR PRINCIPLES
Our values
Rigour
Maintaining rigour as the cornerstone of our work.
Patients first
Putting patients and their needs at the heart of our decisions.
Innovation
Advancing research to develop meaningful therapeutic solutions.
Commitment
Acting with responsibility, consistency and transparency.